IDO1 and ovarian carcinoma: Consistently, three recent reports showed the correlation between the high IDO expression and poor patient prognosis in ovarian cancer, lung cancer, and colorectal cancer (Astigiano et al, 2005; Okamoto et al, 2005; Brandacher et al, 2006), although they only analysed the OS.